GLP-1 vs Semaglutide for weight loss
Short answer: For weight loss, more users report improvement with GLP-1 — 100% of 6 reports, versus 85% of 138 for Semaglutide.
GLP-1 has 1,037 meta-analyses and 1,604 randomized trials on PubMed; Semaglutide has 421 and 307.
Based on 28 reports about GLP-1 and 330 about Semaglutide. Not medical advice.
| GLP-1 Medication | Semaglutide Medication | |
|---|---|---|
| Users say it helped | 78%helped14 reports · few reports | 64%helped228 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 1,037 / 1,604 | 421 / 307 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (6) | 85% (138) |
| Appetite % reporting improvement | — | 80% (70) |
| Energy % reporting improvement | — | 39% (23) |
| Mood % reporting improvement | — | 27% (11) |
| Blood sugar % reporting improvement | — | 90% (10) |
| Common side effects | hair loss, difficulty recovering, stomach issues | nausea, fatigue, stomach issues, constipation |
| Typical dose reported | Not listed | Not listed |
Potent GLP-1 RAs, such as tirzepatide and semaglutide, demonstrate greater overall weight loss but are associated with a significant reduction in lean mass.
Metabolism, 2025 ↗“I felt better, for certain. Think the insulin clearing the excess sugar's really imrove your well being.”
This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Pharmacol Res, 2021 ↗“I've lost 35lbs since then and now I'm in the Healthy range on BMI. My IBSD has virtually disappeared.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate